The Global Nanobiotechnology Market has been projected to grow at the CAGR of 8.2% market during 2017-2025. In 2016, the market has generated the revenue of $ 30,242.5 million and is expected to reach $ 57,892.50 million in terms of revenue by 2025.
Nanobiotechnology mostly studies existing elements of living organisms and other natural sources to fabricate new nano-devices. The decades of in-depth research and development in nano-biotechnology is now assisting access to novel avenues of healthcare such as synthesis of advanced nanofabricated systems and devices for treating several untreatable diseases. Nanobiotechnology possesses the potential to develop breakthrough interface systems that allows interaction between novel electronic devices and biological systems.
Market Segment Insights
The nanobiotechnology market is majorly segmented into application segment which consists of (drug delivery, sequencing, biologic imaging, research tools, microbicide). Drug delivery and sequencing held the largest market in the application segment primarily due to growth factors such as increasing investment in drug formulation and development and high drug efficacy and safety of nanobiotechnology products. The technology segment comprises of bio-nanomaterial, nanoparticles, nanocrystals, quantum dots, liposomes, polymer structures dendrimers, nanopores, and intergrated nanostructures. Liposomes and polymer structure dendrimers held the largest market in the technology segment, the growth is attributed mainly due to rising prevalence of critical illness, and technological advancement in the nano-biotechnology research and development.
North America, Latin America, Europe, Middle East and Africa and Asia Pacific, markets together form the major regional markets for nano-biotechnology. These regional markets are further sub-segmented into country specific markets on the basis of demand and market growth of nano-biotechnology. Among the considered regional markets, North America currently dominates the global nano-biotechnology market, with United States being the largest county-level market. Increase in number of patients suffering from critical illness, rising demand for novel drug therapeutics, and supportive reimbursement policies. On the other hand, Asia Pacific is anticipated to be the fastest growing market for nanobiotechnology as it offers lucrative opportunities for manufacturers involved in nanobiotechnology, due to huge population base suffering from chronic disease, early disease diagnosis and treatment and developed healthcare infrastructure.
Market Competition Assessment:
Key players in the global nano-biotechnology market are: Aduro Biotech, Baxter International, Inc., Biosante Phosphate Pharmaceuticals Inc., Calando Pharmaceuticals Inc., Celgene Corporation, Dendritic nanotechnologies Inc., Elan Pharmaceuticals Inc., Flamel Technologies Inc., Fresinius Kabi AG, Nanophase Technologies Corporation, Sigma Aldrich Company, SkypePharma Pharmaceuticals, Smith and Nephew plc.
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
Chapter 2 Executive Summary
2.1 Global Nanobiotechnology Market, by Technology Type, 2016 ($ Million)
2.2 Global Nanobiotechnology Market, by Application Type, 2016 ($ Million)
2.3 Global Nanobiotechnology Market, by Geography, 2016 (Value %)
Chapter 3 Global Nanobiotechnology Market Overview
3.2 Market Drivers
3.3 Market Restraints
3.4 Market Opportunities
3.5 Attractive Investment Proposition
3.6 Market Competition Assessment: Nanobiotechnology Market, by Key Players
Chapter 4 Global Nanobiotechnology Market Analysis, by Technology Type, 2015-2025 ($ Million)
4.5 Quantum dots
4.7 Polymer Structures Dendrimers
4.9 Integrated Nanostructures
Chapter 5 Global Nanobiotechnology Market Analysis, by Applications, 2015-2025 ($ Million)
5.2 Drug Delivery
5.4 Biologic Imaging
5.5 Research Tools
Chapter 6 Global Nanobiotechnology Market Analysis, by Geography, 2015-2025 ($ Million)
6.1. North America
6.2.3. Rest of Europe
6.3. Asia Pacific
6.3.3. Rest of Asia Pacific
6.4. Latin America
6.4.3. Rest of Latin America
6.5. Middle East and Africa
6.5.2. Rest of Middle East and Africa
Chapter 7 Company Profiles
7.1. Aduro Biotech
7.2. Baxter International, Inc.
7.3. Biosante Phosphate Pharmaceuticals Inc.
7.4. Calando Pharmaceuticals Inc.
7.5. Celgene Corporation
7.6. Dendritic Nanotechnologies Inc.
7.7. Elan Pharmaceuticals Inc.
7.8. Flamel Technologies Inc.
7.9. Fresinuns Kabi AG
7.10. Nanophase Technologies Corporation
7.11. Sigma Aldrich Company
7.12. SkyePharma Pharmaceuticals
7.13. Smith & Nephew plc